-
Information about Project 4: Chronic myeloid leukemia (CML)
Objectives
The main objective of this workpackage is to integrate the leading European national trial groups in CML to form a cooperative network for advancements in CML related research and health care. A clinical trials platform was created to prom ...
-
Contact Persons in Project 4: Chronic myeloblastic leukemia (CML)
Updated list of contact persons (July 2014)
Contact data of WP4
(320KB)
Lead participants and participants of WP4 (CML)
CML, WP4, lead participant
Lead Participants
Name
E-mail
Organisation
Country
B. Simonsson
✍
Upps ...
-
Study Groups of Project 4: Chronic myeloid leukemia (CML)
Name of the study group
Czech Leukemia Study
Group for Life (CELL)
Disease(s)
CML
Leader(s) of the study group
Prof. Jiri Mayer, MD, PhD
Hana Klamova, MD, PhD
Website
http://www.fnbrno.cz/ihok
http://www.uhkt.cz
http://www.leukemia ...
-
Registry for CML
-
Laboratories of Project 4: Chronic myeloblastic leukemia (CML)
Name of the lab
Wissenschaftliches Labor
Hospital
III. Medizinische Universitätsklinik Mannheim
City
Mannheim
Country
Germany
Address
Wiesbadener Str. 7-11, 68305 Mannheim, Germany
+49(0)621 383-4131 (phone), +49(0)621 383-4248 (fa ...
-
Research activities of Project 4: CML
-
CML-Contributions for the Information Letter
Articles from the Information Letter
-
Publications
Baccarani M, Martinelli G, Rosti G, Trabacchi E, Testoni N, Bassi S, Amabile M, Soverini S, Castagnetti F, Cilloni D, Izzo B, De Vivo A, Messa E, Bonifazi F, Poerio A, Luatti S, Giugliano E, Alberti D, Fincato G, Russo D, Pane F, Saglio G and GIMEMA ...
-
The EUTOS long-term survival (ELTS) score
Prognosis of long-term survival in chronic myeloid leukemia (CML) patients: Online calculation of the prognostic risk group of the ELTS score. For adult patients diagnosed with chronic myeloid leukemia (CML).
-
Online calculation of the EUTOS Score
The new EUTOS score predicts complete cytogenetic remission (CCgR) 18 months after the start of therapy, which is an important predictor for the course of disease. Patients without CCgR at this point of treatment are less likely to achieve one later on ...
-
Calculation of Relative Risk of CML Patients
CHRONIC MYELOID LEUKEMIACALCULATION OF RELATIVE RISK (RR)
Age:
years
Spleen:
max. distance from costal margin cm x 10 (e.g. 6 cm = 60)
Platelet:
Plt 109 L ( e.g 350000
ml = 350 )
Blood Basophils:
% x 10 ( e.g. 1.5% = 15 )
...
-
Dates and Meetings
18. ELN/21. KNL Symposium
2022-03-15
- 2022-02-15
7th New Directions in Leukaemia Research (NDLR) meeting
2018-03-25
- 2018-03-28
Brisbane Convention & Exhibition Centre
XXVIII IACRLRD Symposium
2017-10-30
- 2017-11-01
Housto ...
-
Minutes and programs of past meetings
Minutes & Programs
Program ESH Genoa / Italy 2005
(303KB)
THIRD ESH INTERNATIONAL CONFERENCE ON CHRONIC MYELOID LEUKAEMIA IN THE 21st CENTURY 11-13 November, 2005; Genoa, Italy
Welcome to ELN WP4 CML
CML Tue, Sep 1, 2020 2:00 PM - 4:0 ...
-
Links
Chronic myelogenous leukemia (CML):
http://annonc.oxfordjournals.org/cgi/reprint/16/suppl_1/i52
Work Packages: WP04, Physicians
Chronic Myelogenous Leukemia:
http://www.leukemia-lymphoma.org/all_page?item_id=8501
Work Packages: WP04, Patients
Chron ...
-
Recommendations for Project 4 CML
Management of chronic myeloid leukemia (CML): recommendations from the European LeukemiaNet (ELN)
Definitions of failure, suboptimal response, warnings and optimal response
CML Pocketcard_English
(87KB)
Updated CML-Pocketcard 2013
...